TGFB1 and breast carcinoma: Researchers have shown in a mouse model that human epidermal growth factor receptor 2 (HER2) modulates TGF-β signaling through the AKT-mediated phosphorylation of Smad3, promoting cell migration and EMT of breast cancer cells [108].